Cardiff Lexington Corporation (CDIX)
| Previous Close | 4.0000 |
| Open | 4.0000 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 4.0000 - 4.0000 |
| 52 Week Range | 1.5000 - 105.0003 |
| Volume | |
| Avg. Volume | 88 |
| Market Cap | 43.61M |
| Beta (5Y Monthly) | 0.60 |
| PE Ratio (TTM) | 0.03 |
| EPS (TTM) | 156.0000 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
ACCESSWIRECardiff Lexington Announces Fourth Quarter and Full Year 2023 Financial Results
- Full Year 2023 Highlighted by Strong Revenue Growth and Profitability - FT. LAUDERDALE, FL / ACCESSWIRE / March 28, 2024 / Cardiff Lexington Corporation (OTC PINK:CDIX) announced today financial results for its fourth quarter and year ended December ...
- ACCESSWIRE
Cardiff Lexington Opens Eleventh Nova Ortho and Spine Location in Valdosta, Georgia
First Nova Ortho and Spine location outside of the state of Florida marks key milestone in growth strategy FT. LAUDERDALE, FL / ACCESSWIRE / February 28, 2024 / Cardiff Lexington Corporation (OTC PINK:CDIX) today announced the opening of a new Nova ...
- ACCESSWIRE
Cardiff Lexington Appoints Dr. Kevin Fitzgerald, M.D. as Managing Director of Nova Ortho and Spine
Enhancing Leadership to Position Company for Next Stage Growth FT. LAUDERDALE, FL / ACCESSWIRE / January 16, 2024 / Cardiff Lexington Corporation (OTC Pink:CDIX), an acquisition holding company focused on locating, acquiring, and building middle market, ...
